Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease
Cognitive impairment is a common non-motor symptom of Parkinson's disease (PD), which often progresses to PD dementia. PD patients with and without dementia may differ in certain biochemical parameters, which could thus be used as biomarkers for PD dementia. The enzyme paraoxonase 1 (PON1) has...
Saved in:
Main Authors: | Boštjan Petrič (Author), Sara Redenšek Trampuž (Author), Vita Dolžan (Author), Milica Gregorič Kramberger (Author), Maja Trošt (Author), Nikola Maraković (Author), Marko Goličnik (Author), Aljoša Bavec (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves
by: Marko Goličnik, et al.
Published: (2020) -
Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
by: Sara Redenšek, et al.
Published: (2019) -
Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease
by: Tina Levstek, et al.
Published: (2021) -
Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer's Disease and Dementia
by: David Vogrinc, et al.
Published: (2023) -
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
by: Evangelia Eirini Tsermpini, et al.
Published: (2022)